- Contractors
- Inhalon Biopharma, Inc.
Inhalon Biopharma, Inc.
Federal contractor · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Inhalon Biopharma has 2 federal contracts of $100,000 or more active since October 2023, with $5.41M obligated, from 1 agency. 2 are still running, 2 ending within 18 months.
- Contracts
- 2 since FY2024$5,410,293 obligated, contracts of $100,000 or more
- Running now
- 2 contracts
- Biggest customer
- Defense Health Agency$5.41M on 2 contracts
- UEI
- HFQSJ2GMNRU6Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2024 | $2,234,650 |
| FY2025 | $3,175,643 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Developing in-007 As a Widely Deployable Inhaled Treatment Against Pathogens Utilizing Human ACE2 for Viral Attachment and EntryDefense Health Agency · HT942524C0076 | $2,234,650 | Dec 22, 2026in 1 month | NC |
| A Phase 1 Placebo-Controlled Dose-Escalation Safety and Pharmacokinetic Study of in-007, a Nebulized, Pan-Sars ACE2-Decoy Therapeutic for Pandemic PreparednessDefense Health Agency · HT942525CE039 | $3,175,643 | Dec 31, 2027in 13 months | NC |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Defense Health Agency2 contracts | $5,410,293 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 · 2 contracts | $5,410,293 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| North Carolina2 contracts | $5,410,293 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Defense Health Agency: see the list.
Get new notices like Inhalon Biopharma's work
New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy